Arrowhead Pharmaceuticals Reports $450.8 Million in 2026 Revenue and $724.2 Million Net Loss

Arrowhead Pharmaceuticals reported fiscal 2026 revenue of $450.8 million, compared with $829.4 million in fiscal 2025, and a net loss attributable to the company of $724.2 million. The company’s operating loss was $707.2 million, versus operating income of $98.3 million a year earlier. Commercial a…